THE VALUE OF NEOADJUVANT THERAPY IN LOCALIZED PROSTATE CANCER
- 1 March 1995
- journal article
- review article
- Published by Wiley in International Journal of Urology
- Vol. 2 (1) , 1-5
- https://doi.org/10.1111/j.1442-2042.1995.tb00611.x
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Neoadjuvant hormonal therapy and radical prostatectomy for clinical stage C carcinoma of the prostateBritish Journal of Urology, 1994
- Hormone therapy prior to radical prostatectomy in patients with clinical stage C prostate cancerThe Prostate, 1994
- Neoadjuvant androgen blockade prior to prostatectomy: A retrospective study and critical reviewThe Prostate, 1994
- Pathologic changes associated with androgen deprivation therapy for prostate cancerCancer, 1991
- Effect of Combination Endocrine Therapy (LHRH Agonist and Flutamide) on Normal Prostate and Prostatic AdenocarcinomaThe American Journal of Surgical Pathology, 1991
- Cancer in the European community and its member statesEuropean Journal of Cancer and Clinical Oncology, 1990
- NATURAL HISTORY OF LOCALISED PROSTATIC CANCERThe Lancet, 1989
- PATTERNS OF PROGRESSION IN PROSTATE CANCERThe Lancet, 1986
- COMBINED TREATMENT WITH LHRH AGONIST AND PURE ANTIANDROGEN IN ADVANCED CARCINOMA OF PROSTATEThe Lancet, 1984
- Prostatic Carcinoma Cured with Hormonal TreatmentScandinavian Journal of Urology and Nephrology, 1981